VEGF121b and VEGF165b are weakly angiogenic isoforms of VEGF-A
2010

VEGF121b and VEGF165b: Weak Angiogenic Isoforms of VEGF-A

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): Catena Raúl, Larzabal Leyre, Larrayoz Marta, Molina Eva, Hermida Jose, Agorreta Jackeline, Montes Ramon, Pio Ruben, Montuenga Luis M, Calvo Alfonso

Primary Institution: University of Navarra, Pamplona, Spain

Hypothesis

VEGFxxxb isoforms may inhibit angiogenesis.

Conclusion

VEGF121/165b are weakly angiogenic isoforms of VEGF-A that may promote tumor growth and angiogenesis in vivo.

Supporting Evidence

  • VEGF121/165b proteins activated VEGFR2 and increased endothelial cell proliferation.
  • Immunohistochemical analysis showed increased expression of VEGFxxxb in breast cancer compared to normal tissues.
  • VEGF121b and VEGF165b overexpression in xenograft models led to increased tumor volume.

Takeaway

This study found that two specific forms of a protein called VEGF can help tumors grow by making new blood vessels, but they are not very strong at doing this.

Methodology

Recombinant proteins were produced in yeast, and their effects on endothelial cells and tumor growth were assessed in vitro and in vivo.

Limitations

The study primarily focused on specific cancer types and may not generalize to all cancers.

Participant Demographics

Breast cancer patients and normal breast tissue samples were analyzed.

Statistical Information

P-Value

p < 0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1476-4598-9-320

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication